Dr. Peter Barry is Professor Emeritus at the University of California, Davis, with expertise in pathobiology and translational science. His research centers on infection of rhesus macaques with rhesus cytomegalovirus (RhCMV), a model he established to investigate the mechanisms of viral persistence, immune evasion, and pathogenesis. This work has provided critical insights into human CMV biology and opportunities for therapeutic intervention.

Dr. Barry has a strong record of entrepreneurship and commercialization, actively translating scientific discoveries into new technologies. His career includes leading efforts to develop antiviral strategies and advancing academic–industry partnerships.

Peter Barry As an advisor to SyntherionBio, he brings deep experience in viral pathogenesis, translational immunology, and entrepreneurial innovation.